| Group 1 CVD+ DM+ | Group 2 CVD− DM+ | Group 3 CVD+ DM− | Group 4 CVD− DM− | p value | |
---|---|---|---|---|---|---|
WB-MRA | ||||||
 WB SAS | 4 (0–41.1)** | 3.23 (0–19.4) | 10.1 (0–39.5)** | 2.4 (0–19.4) | <0.001 | |
 Head/neck-SAS | 5.6 (0–11.8)^ | 2.8 (2.8–5.6) | 5.6 (2.8–9.0) | 0 (0–5.6) | 0.024 | |
 Aorta-SAS | 8.3 (0–16.7) | 0 (0–8.3) | 16.7 (8.3–16.7)** | 8.3 (0–8.3) | <0.001 | |
 Abdomen-SAS | 0 (0–10) | 0 (0–5) | 5 (0–15)* | 0 (0–10) | 0.02 | |
 Ilio-femoral-SAS | 4.2 (0–22.9)* | 4.2 (0–8.3) | 18.8 (4.2–30.2)** | 0 (0-10.4) | <0.001 | |
 Run off-SAS | 4.7 (0–19.5)** | 0 (0–3.1) | 3.1 (0–25.8)** | 0 (0–1.6) | <0.001 | |
 Normal vessels | 765** | 1432 | 627** | 779 | <0.001 | |
 Vessels with 1–50 % stenosis | 190 | 251 | 221** | 107 | 0.008 | |
 Vessels with 51–70 % stenosis | 38** | 7 | 24* | 6 | <0.001 | |
 Vessels with 71–99 % stenosis | 24* | 4 | 26** | 6 | 0.002 | |
 Occluded vessels | 22 | 4 | 30** | 1 | <0.001 | |
 Abnormal vessels | 8.5** | 5 | 10.1** | 4.1 | <0.001 | |
 N (%) with >50 % stenosis in any vessel | 19 (56 %)** | 12 (21.8 %) | 20 (66.7 %)** | 11 (38 %) | <0.001 | |
Cardiac MRI | ||||||
 LVM (g/m2) | 60.5 (45–86)** | 54.4 (39–95) | 60 (41–86)** | 50.9 (35–73) | 0.001 | |
 LVEDV (ml/m2) | 71.2 ± 14.5 | 66.9 ± 12.8 | 74.9 ± 19.8 | 68.7 ± 9.9 | 0.096 | |
 LVESV (ml/m2) | 24.4 (9–58) | 22.4 (11–55) | 25.1 (11–90) | 24.9 (13–38) | 0.52 | |
 LVEF (%) | 64.6 ± 11.3 | 65.9 ± 8.8 | 64.3 ± 10.3 | 66 ± 7.4 | 0.83 | |
 LVSV (ml/m2) | 45.3 ± 9.2 | 43.7 ± 8.2 | 47 ± 8.2 | 45.1 ± 7.2 | 0.37 | |
 LVMVR (g/ml) | 0.88 ± 0.14^ | 0.84 ± 0.13 | 0.83 ± 0.16 | 0.78 ± 0.14 | 0.036 | |
 LVGFI | 0.43 ± 0.09 | 0.45 ± 0.08 | 0.44 ± 0.08 | 0.47 ± 0.07 | 0.21 | |
 LGE (%) | 9 (29)* | 3 (5.5) | 11 (38)* | 0 (0) | <0.001 |